Breaking News

Breaking News | Promotions & Moves

Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer

Schetter has a proven track record across the entire biopharmaceutical value chain.

09.20.21

Breaking News | cGMP Manufacture | Drug Development | Industry News

Everest Medicines, Sinovent, SinoMab Enter Global BTK Inhibitor Mfg. Pact

To develop, produce and commercialize XNW1011, a covalent reversible BTK inhibitor, globally for the treatment of renal diseases.

09.17.21

Breaking News | Industry News

Lilly’s Antibody Treatment Gets EUA for Post-Exposure COVID Prevention

Phase 3 study shows bamlanivimab 4200 mg reduced the risk of contracting symptomatic COVID-19 by up to 80 percent in nursing home residents.

09.17.21

Breaking News | Collaborations & Alliances | Industry News

Asychem Partners with LaNova Medicines

Will provide one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.

09.16.21

Tevogen Completes Tech Transfer to CDMO BioCentriq

Reaches commercial manufacturing readiness milestone for its investigational COVID-19 therapy TVGN-489.

09.16.21

BioVaxys Reports Progress on Covid-19 Vax Candidate

Bioproduction partner Wuxi Biologics completes synthesis of recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH programs.

09.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Vaccine Developer Intravacc Adopts Hybrid Business Model

Aims to spur further innovation and sustainable growth over the next five years.

09.16.21

Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Clean Cells Expands Bioproduction Capabilities

Invests $15.3 million in new biopharmaceutical production site.

09.16.21

Breaking News | Facilities | Industry News | Inspections

Symbiosis Completes Successful MHRA Audit

Will expand facility at its Stirling, UK site with new storage and warehousing capability.

09.16.21

Breaking News | Cold Chain Management | Facilities | Industry News | Packaging & Tracking

Tower Cold Chain to Open New Global Headquarters in the UK

The 26,000 sq. ft building will greatly expand Tower’s container conditioning and storage capacities.

09.16.21

Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments

Catalent Signs Commercial Supply Agreement with Phathom Pharmaceuticals

Will make lead compound vonoprazan from Winchester, KY facility if approved by FDA.

09.16.21

Breaking News | Clinical Trials

Syneos Health Acquires Clinical Trial Recruitment and Retention Company StudyKIK

Accelerates product development by better connecting patients, sites and communities.

09.15.21

Breaking News | Drug Development | Industry News

Diadem Biotherapeutics Awarded the First Amgen Golden Ticket

Will receive one year of lab space at BioLabs LA at The Lundquist Institute and additional facility benefits and connections to Amgen's scientific leaders.

09.15.21

Breaking News | Industry News

U.S. Govt. to Purchase Additional Doses of REGEN-COV Antibody Cocktail

Will supply an additional 1.4 million 1,200 mg doses of REGEN-COV to the U.S. government by January 31, 2022.

09.15.21

Breaking News | Information Technology

LabVantage Solutions Launches LabVantage Enterprise SaaS

Incorporates the advantages of LabVantage’s standard SaaS option, along with unprecedented software configurability and interfacing capabilities.

09.15.21

Breaking News | Clinical Trials | Collaborations & Alliances

Hookipa Enters Clinical Collaboration & Supply Agreement with Merck & Co.

Will evaluate HB-200 in combination with Keytruda (pembrolizumab) in patients with advanced head and neck cancers.

09.15.21

Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology

Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease

Initiative, together with the Broad Institute of MIT and Harvard, aims to accelerate efforts to mine genetic data for insights into disease mechanisms.

09.15.21

Breaking News | Industry News

U.S. Govt. Purchases Additional Doses of Lilly's Antibody Therapies for COVID

Will supply 388,000 doses of etesevimab to complement doses of bamlanivimab previously purchased, with approximately 200,000 doses expected to ship 3Q21.

09.15.21